Axa’s Avon Products, Inc. AVP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-416,615
Closed -$1.83M 1371
2019
Q3
$1.83M Hold
416,615
0.01% 880
2019
Q2
$1.62M Buy
416,615
+74,701
+22% +$249K 0.01% 881
2019
Q1
$1M Buy
341,914
+320,314
+1,483% +$806K ﹤0.01% 977
2018
Q4
$33K Hold
21,600
﹤0.01% 1290
2018
Q3
$48K Hold
21,600
﹤0.01% 1324
2018
Q2
$35K Hold
21,600
﹤0.01% 1339
2018
Q1
$61K Hold
21,600
﹤0.01% 1357
2017
Q4
$46K Hold
21,600
﹤0.01% 1339
2017
Q3
$50K Sell
21,600
-940,060
-98% -$2.79M ﹤0.01% 1306
2017
Q2
$3.65M Sell
961,660
-99,600
-9% -$389K 0.02% 669
2017
Q1
$4.67M Sell
1,061,260
-118,900
-10% -$594K 0.02% 608
2016
Q4
$5.95M Buy
1,180,160
+1,121,560
+1,914% +$6.52M 0.03% 533
2016
Q3
$332K Buy
+58,600
New +$292K ﹤0.01% 1085
2015
Q2
Sell
-102,350
Closed -$818K 1482
2015
Q1
$818K Buy
102,350
+44,450
+77% +$369K ﹤0.01% 994
2014
Q4
$544K Buy
57,900
+54,800
+1,768% +$567K ﹤0.01% 1093
2014
Q3
$39K Buy
+3,100
New +$42.5K ﹤0.01% 1374
2014
Q1
Sell
-3,117,610
Closed -$53.7M 1486
2013
Q4
$53.7M Buy
3,117,610
+553,710
+22% +$10.3M 0.24% 120
2013
Q3
$52.8M Buy
2,563,900
+559,442
+28% +$12M 0.26% 98
2013
Q2
$42.2M Buy
+2,004,458
New +$45M 0.22% 120

Other funds holding AVP

Axa's AVP Position: Q4 2019 in Review

Axa sold out of Avon Products, Inc. (AVP) in Q4 2019, closing a stake of 416,615 shares — an estimated $1.83M sold.

Axa first reported a position in AVP in Q2 2013 and held it in 19 quarters. The position peaked at $53.7M in Q4 2013. 176 funds tracked by Wall St. Rank hold AVP as of Q4 2019.

  • Axa reported no remaining Avon Products, Inc. position as of Q4 2019 after selling out during the quarter.
  • Axa sold 416,615 Avon Products, Inc. shares in Q4 2019, an estimated $1.83M.
  • Axa first reported a position in Avon Products, Inc. in Q2 2013 and held it in 19 quarters.
  • Axa's Avon Products, Inc. position peaked at $53.7M in Q4 2013.
  • 176 funds tracked by Wall St. Rank held Avon Products, Inc. as of Q4 2019.

Based on Axa's 13F filing for Q4 2019, filed 18 Feb 2020.